Skip to main content
. 2022 Jun 28;14:1203–1211. doi: 10.2147/NSS.S361529

Table 1.

Descriptive Variables and Comparisons Among Groups

Full Sample (n=122) No/Mild OSAa (n=35) Moderate OSAb (n=31) Severe OSAc (n=56) p
Age 72.0 (5.75) 70.0 (5.50) 71.0 (6.0) 73.0 (5.7) 0.202
AHI 26.6 (35.8) 9.4 (3.9) 22.0 (4.7) 53.7 (33.6) <0.001 (c>b>a)
RDI 26.6 (36.2) 9.4 (3.9) 22.4 (4.7) 54.7 (33.6) <0.001 (c>b>a)
SpO2 average 92.0 (3.0) 92.0 (4.0) 92.0 (2.7) 91.0 (3.2) 0.045 (c<a)
SpO2 minimum 82.0 (9.0) 85.0 (5.0) 83.0 (5.5) 78.0 (12.5) <0.001 (c<(a=b))
SpO2 <90% 9.65 (29.5) 2.9 (22.4) 9.6 (24.0) 15.0 (36.8) 0.003 (c>a)
Days - Vaccination to testing 58.5 (30.8) 50.0 (37.5) 57.0 (27.5) 62.0 (32.0) 0.211
Sex - Female 80 (65.6%) 28 (80.0%) 18 (58.1%) 34 (60.7%) 0.101
Vaccine
 Coronavac 111 (91.0%) 32 (91.4%) 27 (87.1%) 52 (92.9%) 0.664
 Oxford/AstraZeneca 11 (9.0%) 3 (8.6%) 4 (12.9%) 4 (7.1%)

Notes: All continuous/numeric data have non-parametric distributions (Shapiro–Wilk’s p>0.05), are presented as median and interquartile range and were compared using Kruskal–Wallis’ test followed by Dwass-Steel-Critchlow-Fligner pairwise comparison. Categorical data are presented as counts and percentage and were compared with X2 test. Pos-hoc coding: a=no/mild OSA; b=moderate OSA, and c=severe OSA.

Abbreviations: AHI, apnea-hypopnea index; OSA, obstructive sleep apnea; RDI, respiratory disorder index; SpO2, percutaneous oxygen saturation; SpO2<90%, percentage of SpO2<90% out of the total sleep time.